AbbVie Lunch & Learn

Topic: AbbVie is a global biopharmaceutical company where our business is to fight the toughest health challenges. We are committed to developing innovative advanced therapies for some of the world's most complex and critical conditions across four primary therapeutic areas: immunology, oncology, virology, and neuroscience. Global Market Access & Pricing is a growing capability that is critical to AbbVie's ongoing success.
Come learn about AbbVie's Market Access programs and how our group is ensuring that patients across the world have access to our medicines. In this session, we'll dive into the internal and external factors that impact our business, as it is highly dynamic and complex. We're looking forward to an interactive session!
Speakers: Dalia Mahmoud, Vice President and Head of Global Market Access and Pricing Oncology; Bill Nihill, Director, Global Market Access & Pricing

Healthcare Club | Website | View More Events

Contact the organizers